Fucoxanthin Inactivates the PI3K/Akt Signaling Pathway to Mediate Malignant Biological Behaviors of Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Fucoxanthin Inactivates the PI3K/Akt Signaling Pathway to Mediate Malignant Biological Behaviors of Non-Small Cell Lung Cancer

Published:2022-07-15 Issue:10 Volume:74 Page:3747-3760
ISSN:0163-5581
Container-title:Nutrition and Cancer
language:en
Short-container-title:Nutrition and Cancer

Author:

Fang Xuehong¹,Zhu Yuzhen¹,Zhang Taomin²,Li Qian¹,Fan Lvhua¹,Li Xiaodan³,Jiang Daishun¹,Lin Jie²,Zou Liyi²,Ren Jianwei⁴,Huang Zunnan²,Ye Hua¹,Liu Yi¹

Affiliation:

1. Guangdong Key Laboratory for Research and Development of Natural Drugs, Marine Biomedical Research Institute, Department of Pharmacology, Guangdong Medical University, Southern Marine Science and Engineering Guangdong Laboratory (Zhanjiang), Zhanjiang, Guangdong, China

2. Department of Pharmacology, Guangdong Medical University, Dongguan, Guangdong, China

3. People’s Hospital of Longhua District, Shenzhen, Guangdong, China

4. Shenzhen Ritzcon Biological Technology Co., LTD, Shenzhen, Guangdong, China

Publisher

Informa UK Limited

Subject

Cancer Research,Nutrition and Dietetics,Oncology,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/01635581.2022.2091149

Reference58 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: Results From the CA209-003 Study